Catalyst Wire Dossier Catalyst Wire Dossier

InO

inotuzumab ozogamicin · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for InO, covering 2022-03-31 to 2022-03-31. Get the full timeline:

Most recent: Clinical Trial Update: InO - A Retrospective Study of UK Patients With Leukaemia

See pricing